Literature DB >> 9832294

Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury.

J F Stover1, R Stocker.   

Abstract

OBJECTIVES: Barbiturate coma is employed in brain-injured patients whenever increases in intracranial pressure remain unresponsive to less aggressive therapeutic regimens. Barbiturate-mediated neuroprotection, however, is weakened by an increased infection rate related to barbiturate-induced immunosuppression. Co-administration of barbiturates with antibiotics known to induce bone marrow suppression could, in turn, potentiate barbiturate-mediated immunosuppression. Adverse drug reactions and interactions of thiopental with antibiotics in terms of leukopenia, infection rate, and bone marrow suppression were investigated.
METHODS: White blood cells were measured daily, tracheobronchial secretion and urine were examined for bacterial growth twice a week or if an infection was suspected.
RESULTS: A total of 52 patients with severe isolated head injury were consecutively investigated. Due to increased intracranial pressure (ICP), which did not respond to analgosedation, barbiturate coma was performed in 23 cases. The other 29 patients remained analgosedated. Leukocytes and neutrophils were reversibly and significantly decreased in all patients, mostly sustained under thiopental. The pulmonary infection rate due to gram-negative organisms was nearly doubled during barbiturate coma. Reversible agranulocytosis and bone marrow suppression attributed to antibiotics developed in six patients after thiopental administration. Mortality rate, however, was not increased by these adverse effects.
CONCLUSIONS: Barbiturate coma may cause reversible leukopenia and an increased infection rate. Long-term administration of thiopental may also promote reversible antibiotic-induced bone marrow suppression. The mechanisms and site of interaction between thiopental and antibiotics cannot be assessed by the present study and remain to be clarified. However, during and after barbiturate coma, close monitoring of leukocytes and infections and careful selection of antibiotics is required.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832294     DOI: 10.1007/s002280050508

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

3.  Reply to: Measurement of intracranial pressure and short-term outcomes of patients with traumatic brain injury: a propensity-matched analysis.

Authors:  Cesar Biselli Ferreira; Luiz Marcelo Malbouisson; Estevão Bassi; Fernando Godinho Zampieri
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

Review 4.  [Evidence-based intensive care treatment of intracranial hypertension after traumatic brain injury].

Authors:  B H J Pannen; T Loop
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

5.  Severe traumatic brain injury in Austria IV: intensive care management.

Authors:  Walter Mauritz; Ivan Janciak; Ingrid Wilbacher; Martin Rusnak
Journal:  Wien Klin Wochenschr       Date:  2007-02       Impact factor: 1.704

6.  Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury.

Authors:  Mitchell Hamele; Chris Stockmann; Meghan Cirulis; Jay Riva-Cambrin; Ryan Metzger; Tellen D Bennett; Susan L Bratton
Journal:  J Neurotrauma       Date:  2015-10-02       Impact factor: 5.269

7.  Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Corinne Lerch; Yasuhiro Yonekawa; Carl Muroi; Miroslava Bjeljac; Emanuela Keller
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

8.  Risk factors and pathogens involved in early ventilator-acquired pneumonia in patients with severe subarachnoid hemorrhage.

Authors:  R Cinotti; A Dordonnat-Moynard; F Feuillet; A Roquilly; N Rondeau; D Lepelletier; J Caillon; N Asseray; Y Blanloeil; B Rozec; K Asehnoune
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-10       Impact factor: 3.267

9.  Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus.

Authors:  Christopher R Newey; Dolora Wisco; Premkumar Nattanmai; Aarti Sarwal
Journal:  Ther Adv Drug Saf       Date:  2016-07-18

10.  Propylene glycol toxicity complicating use of barbiturate coma.

Authors:  Kathleen A Bledsoe; Andreas H Kramer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.